Literature DB >> 903187

Increased ferritin synthesis and release by Hodgkin's disease peripheral blood lymphocytes.

E J Sarcione, J R Smalley, M J Lema, L Stutzman.   

Abstract

Peripheral blood lymphocytes from patients with all stages of untreated Hodgkin's disease and from normal healthy adults were shown to synthesize and release ferritin in vitro. Ferritin synthesis was confirmed by immunoelectrophoresis, double immunodiffusion and autoradiography. Hodgkin's disease lymphocytes synthesized ferritin 4.2 times faster and released it 2.4 times faster than did normal lymphocytes, whereas total protein synthesis was faster in normal lymphocytes. Patients with nodular sclerosis and perhaps those with absence of fever had the highest synthetic rates; however no relationship was observed between relative rates of lymphocyte ferritin synthesis and sex, age, anatomical stage and presence of splenic or hepatic involvement by tumor. Addition of iron to normal human lymphocytes produced little or no change in ferritin synthesis. These data indicate that part of the intracellular ferritin detected in peripheral blood lymphocytes from patients with Hodgkin's disease and from normal individuals resulted from de novo synthesis rather than from uptake and storage of serum ferritin, and suggests that elevated ferritin levels detected in the serum and tumor tissue of Hodgkin's disease patients originate from lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 903187     DOI: 10.1002/ijc.2910200304

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  The Reed-Sternberg cell/lymphocyte interaction: ultrastructure and characteristics of binding.

Authors:  S V Payne; D G Newell; D B Jones; D H Wright
Journal:  Am J Pathol       Date:  1980-07       Impact factor: 4.307

2.  Tissue ferritin concentration and prognosis in carcinoma of the breast.

Authors:  R E Weinstein; B H Bond; B K Silberberg; C B Vaughn; P Subbaiah; D R Pieper
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

3.  Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue.

Authors:  R Rossiello; M V Carriero; G G Giordano
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

Review 4.  Serum ferritin and malignant tumours.

Authors:  A Jacobs
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

5.  Subpopulations of human T lymphocytes. XVI. Maldistribution of T cell subsets associated with abnormal locomotion of T cells in untreated adult patients with Hodgkin's disease.

Authors:  S Gupta
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

Review 6.  Plasma ferritin concentrations: their clinical significance and relevance to patient care.

Authors:  L S Valberg
Journal:  Can Med Assoc J       Date:  1980-06-07       Impact factor: 8.262

7.  High serum erythropoietin and ferritin levels in conjunction with anemia response in malignant lymphoma.

Authors:  Sofia Omari; Alhossain Khalafallah; Mahmoud Ayesh; Ismail Matalka; Raji Al-Hadithi
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-16       Impact factor: 2.576

8.  Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer.

Authors:  K Pattanapanyasat; T G Hoy; A Jacobs; S Courtney; D J Webster
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.